Company Changchun BCHT Biotechnology Co.

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2025-06-12			5-day change	1st Jan Change
21.66 ^CNY	+1.59%		+1.83%	-13.74%

04-20	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
04-20	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Business description: Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.

Number of employees: 1,241

Sales by Activity: Changchun BCHT Biotechnology Co.

Fiscal Period: December	2020	2021	2022	2023	2024
Biotechnology	1.44B	1.2B	1.07B	1.82B	-

See all business segments

Geographical breakdown of sales: Changchun BCHT Biotechnology Co.

Fiscal Period: December	2020	2021	2022	2023	2024
Hong Kong, Macao and Taiwan	-	5M	-	-	-
Foreign	8.44M	18.21M	20.16M	35.16M	-
Northeast District	69.7M	50.86M	39.25M	96.42M	-
North-West Area	89.81M	121M	86.52M	142M	-
Northern Region	103M	118M	95.58M	195M	-
Southwest	183M	144M	139M	281M	-
Central China	259M	152M	134M	290M	-
Southern Region	212M	208M	217M	282M	-
Eastern Region	515M	385M	340M	502M	-

See all geographic segments

Executive Committee: Changchun BCHT Biotechnology Co.

Manager	Title	Age	Since
Wei Kong CEO	Chief Executive Officer	60	2003-12-31
Zhao Feng Meng DFI	Director of Finance/CFO	61	2019-01-31
Chang Lin Zhu CTO	Chief Tech/Sci/R&D Officer	57	2003-12-31
Chun Lai Jiang CTO	Chief Tech/Sci/R&D Officer	52	2009-06-30
Xiu Feng Li PRN	Corporate Officer/Principal	56	2004-02-29

See CHANGCHUN BCHT BIOTECHNOLOGY CO. governance

Composition of the Board of Directors: Changchun BCHT Biotechnology Co.

Director	Title	Age	Since
Xiu Feng Li BRD	Director/Board Member	56	2004-02-29
Yun Tao Jiang BRD	Director/Board Member	51	2018-06-30
Wei Kong BRD	Director/Board Member	60	2003-12-31
Chun Lai Jiang BRD	Director/Board Member	52	2009-06-30
Jing Liu BRD	Director/Board Member	63	2020-05-31
Bai Nian Fu BRD	Director/Board Member	69	2020-05-31
Da Yong Xu BRD	Director/Board Member	61	2020-06-18
Da Qiang Feng CHM	Chairman	59	2020-03-09
De Shen Zhang BRD	Director/Board Member	61	2019-02-20
Yang Yang BRD	Director/Board Member	40	2020-06-18

Composition of the Board of Directors

Shareholders: Changchun BCHT Biotechnology Co.

Name	Equities	%	Valuation
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. 41.46 %	171,488,182	41.46 %	503 M ¥
Wei Kong 25.25 %	104,448,497	25.25 %	306 M ¥
Xue Ning Wei 5 %	20,682,880	5 %	61 M ¥
Shang Shu Hu 1.45 %	6,000,000	1.45 %	18 M ¥
Xiao Hui Chen 1.326 %	5,485,733	1.326 %	16 M ¥

List of CHANGCHUN BCHT BIOTECHNOLOGY CO. shareholders

Company details: Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co.

1260 Huoju Road Changchun High-tech Zone

130103, Jillin

http://www.bchtpharm.com

address Changchun BCHT Biotechnology Co.(688276)

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
CHANGCHUN BCHT BIOTECHNOLOGY CO.	+1.59%	+1.83%	-31.89%	-52.17%	1.25B
MERCK KGAA	-1.46%	-0.26%	-33.31%	-31.44%	58.6B
KYOWA KIRIN CO., LTD.	0.00%	+2.28%	-7.32%	-12.65%	9.07B
HALOZYME THERAPEUTICS, INC.	+1.28%	+1.85%	+9.83%	+24.55%	6.72B
YUHAN CORPORATION	+1.12%	+4.43%	+45.90%	+108.94%	5.96B
SK BIOPHARMACEUTICALS CO., LTD.	+0.32%	+3.43%	+17.17%	+15.43%	5.4B
BETTA PHARMACEUTICALS CO., LTD.	+2.04%	+4.18%	+68.71%	+27.47%	3.79B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+0.09%	+2.33%	+0.18%	+21.28%	2.06B
SUPERNUS PHARMACEUTICALS, INC.	-1.15%	+1.33%	+21.01%	+20.70%	1.83B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-1.08%	-3.93%	-61.53%	-4.54%	1.82B
Average	+0.28%	+1.73%	+2.88%	+11.76%	9.65B
Weighted average by Cap.	-0.63%	+1.31%	-14.91%	-9.82%